Metabolic dysfunction-associated steatotic liver disease and gastroesophageal reflux disease: a mendelian randomization study in European and East Asian populations

被引:0
|
作者
Su, Chen'guang [1 ]
Liao, Zheng [1 ]
Li, Hewen [2 ]
Pei, Yinxuan [1 ]
Wang, Zixiang [1 ]
Li, Jian [1 ]
Liu, Jinlong [1 ,3 ]
机构
[1] Chengde Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[2] Chengde Med Univ, Dept Minimally Invas Spine Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[3] Hebei Key Lab Panvasc Dis, Chengde, Hebei, Peoples R China
关键词
metabolic dysfunction-associated steatotic liver disease; gastroesophageal reflux disease; mendelian randomization; causal effect; genome-wide association studies; ALANINE AMINOTRANSFERASE; RISK-FACTORS; ESOPHAGITIS; PREVALENCE; OBESITY; INSTRUMENTS; SYMPTOMS; BIAS;
D O I
10.3389/fgene.2024.1428334
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Numerous observational studies have shown a potential association between metabolic dysfunction-associated steatotic liver disease (MASLD) and gastroesophageal reflux disease (GERD). However, causality is unclear. This study utilized genome-wide association study (GWAS) genetic data to explore the causal relationship between MASLD and GERD in European and East Asian populations. Methods This study utilized a bidirectional, two-sample Mendelian randomization (MR) approach. All disease data were obtained from the GWAS database, and single nucleotide polymorphisms strongly associated with exposure were selected as instrumental variables. The inverse variance weighted (IVW) method is primarily utilized to evaluate the causal relationship between exposure and outcome. Finally, sensitivity analyses were performed to ensure the robustness of the results. Results The IVW estimates indicated that non-alcoholic fatty liver disease (NAFLD) (odds ratio (OR) = 1.054, 95% confidence interval (CI), 0.966-1.150, p = 0.236) and percent liver fat (OR = 0.977, 95% CI, 0.937-1.018, p = 0.258) in European population were not linked to a higher risk of GERD. However, GERD in European population was associated with an increased risk of NAFLD (OR = 1.485, 95% CI, 1.274-1.729, p < 0.001) and percent liver fat (OR = 1.244, 95% CI, 1.171-1.321, p < 0.001). In addition, the IVW analysis in East Asian population showed that alanine aminotransferase (ALT) was associated with an increased risk of GERD (OR = 2.305, 95% CI, 1.241-4.281, p = 0.008), whereas aspartate aminotransferase (AST) had no causal effects on GERD risk (OR = 0.973, 95% CI, 0.541-1.749, p = 0.926). Furthermore, the associations between GERD and ALT (OR = 1.007, 95% CI, 0.998-1.015, p = 0.123) or AST (OR = 1.004, 95% CI, 0.997-1.012, p = 0.246) were not significant. After removing outliers, a significant correlation between GERD and ALT was observed (OR = 1.009, 95% CI, 1.001-1.016, p = 0.020). Conclusion There was reverse causality between MASLD and GERD in European population, while there was bidirectional causality between a proxie for MASLD (ALT) and GERD in East Asian population. This study can provide novel insights into cross-ethnic genetic research on MASLD and GERD.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Genetic associations of birthweight, childhood, and adult BMI with metabolic dysfunction-associated steatotic liver disease: a Mendelian randomization
    Ma, Xiaohui
    Chang, Lina
    Li, Shuo
    Gu, Yian
    Wan, Jieying
    Sang, Hequn
    Ding, Li
    Liu, Ming
    He, Qing
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [2] Gastroesophageal reflux disease and atrial fibrillation: a bidirectional Mendelian randomization study
    Chen, Xiaoli
    Li, Aihua
    Kuang, Yuanyuan
    Ma, Qilin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (07): : 1321 - 1328
  • [3] Menopause and metabolic dysfunction-associated steatotic liver disease
    Polyzos, Stergios A.
    Goulis, Dimitrios G.
    MATURITAS, 2024, 186
  • [4] Association between gastroesophageal reflux disease and stroke: a bidirectional Mendelian randomization study
    Meng, Decheng
    Zhang, Xin
    Yu, Wenfei
    Yin, Guoliang
    Chen, Suwen
    Liu, Hongshuai
    Wang, Linya
    Zhang, Fengxia
    FRONTIERS IN NEUROLOGY, 2024, 14
  • [5] Gastroesophageal Reflux Disease and Rhinosinusitis: A Bidirectional Mendelian Randomization Study
    Chen, Teng-yu
    Lv, Ming-hui
    Lai, Ren-jie
    Hu, Yu-qi
    Ye, Zhong-kang
    Lv, Qi-liang
    Chen, Bao-yi
    Wu, Jun-tao
    Hong, Haiyu
    Li, Shuo
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (02) : 182 - 189
  • [6] Gastroesophageal reflux disease and osteoporosis: A bidirectional Mendelian randomization study
    Yang, Qinghua
    Huang, Longao
    Xu, Hongyuan
    Feng, Junfei
    Liu, Dun
    Wei, Shengwang
    Jiang, Hua
    MEDICINE, 2025, 104 (14) : e42083
  • [7] Exploring the causality between educational attainment and gastroesophageal reflux disease: A Mendelian randomization study
    Chen, Gui
    Xie, Junyang
    Liang, Tianhao
    Wang, Yiyan
    Liao, Wenjing
    Song, Lijuan
    Zhang, Xiaowen
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (09) : 1208 - 1213
  • [8] Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study
    Zhao, Jian
    Zeng, Jing
    Zhu, Cairong
    Li, Xuechao
    Liu, Dong
    Zhang, Jun
    Li, Fei
    Targher, Giovanni
    Fan, Jian-Gao
    BMC MEDICINE, 2023, 21 (01)
  • [9] Association between gastroesophageal reflux disease and venous thromboembolism: A Mendelian randomization study
    Ao, Ting
    Huang, Yingxiu
    Zhen, Peng
    Hu, Ming
    MEDICINE, 2024, 103 (47) : e40680
  • [10] Update in lean metabolic dysfunction-associated steatotic liver disease
    Sato-Espinoza, Karina
    Chotiprasidhi, Perapa
    Huaman, Mariella R.
    Diaz-Ferrer, Javier
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 452 - 464